Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. - Wikidata - wikimedia - TriplyDB

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma.

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma.

http://www.wikidata.org/entity/Q33943344

about

Appraisal of immunoglobulin free light chain as a marker of response Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance Immunoglobulin free light chains and solitary plasmacytoma of bone Non-secretory multiple myeloma: from biology to clinical management Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature.Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis - a pilot study Circulating serum free light chains as predictive markers of AIDS-related lymphoma.Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome.Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study Clinical course and prognosis of non-secretory multiple myeloma.Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests.Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.The evolving use of serum free light chain assays in haematology.Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.Serum N-Glycans: A New Diagnostic Biomarker for Light Chain Multiple Myeloma.Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder.Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy.Renal complications in multiple myeloma and related disorders: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.Prognostic utility of intact immunoglobulin Ig'κ/Ig'λ ratios in multiple myeloma patients.Drug Insight: emerging therapies for amyloidosis.Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipients Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma.Serum Immunoglobulin Free Light Chain Assessment in IgG4-Related Disease.Immunodiagnostic capabilities of anti-free immunoglobulin light chain monoclonal antibodies Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.Screening panels for detection of monoclonal gammopathies.Current trends in the diagnosis, therapy and monitoring of the monoclonal gammopathies.Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study.Immunoglobulin free light chains in adult atopic dermatitis patients do not correlate with disease severity.International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.Renal failure in multiple myeloma: a medical emergency.Guidelines for the diagnosis and management of multiple myeloma 2011.Plasma cell myeloma and related neoplasms.

P2860

Q24624398-E12AE898-AF96-4815-9652-4307BBB0DFA3 Q24653006-95B929CF-C3FF-4D98-9BB5-D36C187D8582 Q24653434-C4FF3320-534C-4B61-9559-A788815665A3 Q24669898-BCBA9263-A36B-446D-B441-7605C95BF7E7 Q24685868-C255CF3B-CA2F-4641-B7C1-FCBC8E29B9B2 Q28074785-FEC78B97-F4A7-45DB-A102-A7C875F45BE9 Q28207984-D5E4F03D-97AA-4DE7-B301-706239672096 Q31146661-5D226076-3051-4F99-84CA-69483963B62D Q33301492-62B888B2-37E9-4006-9D26-CDF936631D4B Q33710567-6A28D02E-D8A4-447B-ADE9-1719588B1BD2 Q33988217-B7777BB9-0602-47FC-BA5E-92D6040C10E2 Q33997173-BC14863A-D441-413D-9577-F377F34BE359 Q34447010-EE70706F-FCAE-4B42-B78E-F1EDE0D907D5 Q34482518-0543D342-E865-420E-AF35-DCEBD05C607C Q34557435-C2A97788-4411-42A2-98F0-79293BBC0E3C Q34615704-78BE6AB8-7A36-4DCC-AF8C-97254807EFF5 Q34758218-722B5D2F-00D7-4B21-8537-385D69666861 Q35638270-9357E860-C1E4-43BD-B441-BC79E03E194A Q35663623-F9696507-790F-4A8E-88C9-64D0BA0FA577 Q35918672-BD5F9FF0-923A-4AA4-AA2E-7FD16FF9B8CA Q36033380-D8821ABE-82FF-477A-A6A8-6AAC8CA27506 Q36137449-8632B5E6-F687-4729-851F-FC7774EF798E Q36209159-BAB4ECA3-02F1-4D0A-A72E-89C0C9C75D9F Q36525224-449EC51C-0588-462D-BA52-2283C2B206B9 Q36577160-CEF6C4EE-5E1F-4C85-A833-FC58D8C10A15 Q36592302-A3843492-F7D1-41C1-A389-5CDC7A4E05F4 Q36777222-CF55803A-61DF-4668-A071-CEE35C1B8D2F Q36777247-F0D9536D-82FD-42ED-94C4-24D5419F5A7A Q37009888-11B57600-7CD0-433B-A6FC-0EBAA24A1BA9 Q37050005-2FF76896-4098-4C40-84DE-C20C268AE595 Q37081473-D0EF6508-D761-41E3-8502-4BE85DF6BB50 Q37172007-9155719B-B8EF-440A-8869-3C38E2461AAA Q37370051-25980BE7-DBA9-48AE-A464-709B80EA95F4 Q37460313-57A387A4-4010-4627-97B1-710B4160F347 Q37476900-7DBE80DD-C345-4245-9AE2-7C5EAF1314F5 Q37507513-C454594C-06AE-4B50-84C4-985AC74990DB Q37821496-C15B8BD6-E2B2-4B9E-A3B5-9D6286342195 Q37845643-260480A9-2504-44F0-AA58-F49114E3E772 Q37875193-75417274-60B9-4D9B-AA92-032A880980FB Q37901231-D2C41042-420C-4520-9935-670CDD9565E9

P2860

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma.

http://www.wikidata.org/entity/Q33943344

description

2001 nî lūn-bûn

@nan

2001 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Serum free light-chain measure ...... nonsecretory multiple myeloma.

@ast

Serum free light-chain measure ...... nonsecretory multiple myeloma.

@en

type

label

Serum free light-chain measure ...... nonsecretory multiple myeloma.

@ast

Serum free light-chain measure ...... nonsecretory multiple myeloma.

@en

prefLabel

Serum free light-chain measure ...... nonsecretory multiple myeloma.

@ast

Serum free light-chain measure ...... nonsecretory multiple myeloma.

@en

P1433

Q33943344-7D494DE7-6AC8-49EA-B967-AFCF71656B40

P1476

Q33943344-1B9B5D30-7199-40ED-B5D9-4B988B8AA4FF

P2093

Q33943344-2A01E2E3-D474-4C88-95A9-1812713E506A

Q33943344-2A22D975-ACC6-46FC-AAEB-16190B813FC5

Q33943344-3221458B-35C3-4A55-9610-485ED290AFFF

Q33943344-7056E17D-61F9-4C6C-A931-D626523A9D25

Q33943344-81F30870-E105-46B7-9FBB-1404E93DBA23

Q33943344-BA59415A-746E-4A40-8555-28D5A5776A67

P304

Q33943344-A412D5AA-E264-4951-9622-FF688C3F54CB

P31

Q33943344-DA60D9D0-9F06-45FB-8688-3EFA1ED8A8F9

P356

Q33943344-0FAC1652-871F-4D8C-9573-6731A763CBDC

P407

Q33943344-623CBC3A-4917-46F4-AD17-36937988A9D8

P433

Q33943344-7F090039-F331-4A91-B44D-05D039C4B7F7

P478

Q33943344-8FD6A129-6EFE-4E11-9A29-3ABB8AE52663

P577

Q33943344-ADF12F04-75F2-4055-9897-9DF1143C6E4D

P698

Q33943344-343B1DC6-F3A7-45DB-A51E-B33D9062C380

P356

BLOOD.V97.9.2900

P1433

P1476

Serum free light-chain measure ...... nonsecretory multiple myeloma.

@en

P2093

Bradwell AR

http://www.w3.org/2001/XMLSchema#string

Carr-Smith H

http://www.w3.org/2001/XMLSchema#string

Drayson M

http://www.w3.org/2001/XMLSchema#string

Drew R

http://www.w3.org/2001/XMLSchema#string

Mead GP

http://www.w3.org/2001/XMLSchema#string

Tang LX

http://www.w3.org/2001/XMLSchema#string

P304

2900-2902

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD.V97.9.2900

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2001-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11313287

http://www.w3.org/2001/XMLSchema#string